Connect with others who understand.

Sign up Log in
Resources
About MyLungCancerTeam
Powered By
See answer
See answer
LUNG CANCER
NEWS

77% of MyLungCancerTeam Members Are Satisfied With Their Doctors, Survey Finds

Written by Kevin Benny
Posted on September 30, 2022

  • MyLungCancerTeam surveyed members to understand their relationships with their doctors.
  • More than three-quarters of the respondents said they’re satisfied with their oncology team, while just 6 percent said they were dissatisfied.
  • Members who are most satisfied with their care said their doctors provided clear explanations and cared about their concerns and preferences.
  • The majority of survey respondents said they’ve either never undergone biomarker testing — used to hone lung cancer treatment — or don’t know what it is.

Having a positive relationship with the doctor who primarily treats your lung cancer is critical to achieving positive outcomes. MyLungCancerTeam conducted a survey to better understand members’ relationships with their care team, including what’s working and where there are challenges.

The survey, conducted in December 2021, included 117 members in the United States who are living with lung cancer.

They were asked questions about their:

  • Satisfaction with their care team
  • Relationship and communication with their care team
  • Experience with and knowledge of biomarker testing

MyLungCancerTeam shares these survey results with members of the community so they can learn from one another’s experiences. To ensure that doctors and pharmaceutical companies hear members’ voices, we also shared the findings of the survey at the International Association for the Study of Lung Cancer World Conference on Lung Cancer in August 2022.

The Majority of Members Are Happy With Their Oncology Team

Three-fourths of MyLungCancerTeam members overall reported being satisfied with their care team (77 percent). Just over half — 55 percent — were very satisfied.

There were a number of specific factors that set doctors apart for the “very satisfied” group. In general, these doctors:

  • Listen to individuals’ specific needs
  • Make them feel heard
  • Show that they care
  • Spend the time to discuss treatment options and allow people to weigh in on treatment decisions

People living with lung cancer sometimes experience emotional challenges associated with their diagnosis. Thus, it’s not surprising that doctors with whom members are most satisfied take the time to understand how members are managing and to address the emotional toll of their diagnoses and corresponding treatments. As one satisfied member wrote, “I love him [my oncologist] to death, also never feel rushed when I talk to him.”

On the other hand, one of the members who was dissatisfied commented: “I’m unhappy with my oncologist for a variety of reasons. The most annoying trait is not answering specific questions about my treatment.”

84% of ‘Very Satisfied’ Members Believe Their Doctor Cares About Their Concerns

Survey respondents who are very satisfied with their care team like that their providers explain things clearly and show concern for their questions and opinions. Among very satisfied survey respondents, 84 percent said their doctor “makes me feel that they care about my concerns and preferences.” Only 23 percent of the respondents who were neutral or dissatisfied agreed with that statement.

Eighty-three percent of very satisfied respondents agreed that their their provider “listens to me and understands my specific needs,” whereas only 19 percent of neutral or dissatisfied respondents agreed with that statement.

Only 29% of Survey Respondents Have Had or Are Scheduled To Have Biomarker Testing

The survey also revealed that many members may not be aware of biomarker testing. Forty-two percent said they either didn’t know what biomarker testing was or if they haven’t had a biomarker test. Only 29 percent of respondents have either had biomarker testing or are scheduled to receive it.

In treating lung cancer — especially non-small cell lung cancer — doctors can use biomarkers to help establish more individualized treatment plans. If a person’s tumor has certain mutations (genetic errors) or makes a specific protein, they may be treated with a more specialized medicine that can target those biomarkers.

Connect With Your Team

MyLungCancerTeam is the social network for people with lung cancer and their loved ones. On MyLungCancerTeam, more than 7,100 members come together to ask questions, give advice, and share their stories with others who understand life with lung cancer.

How do you feel about your relationship with your lung cancer doctor and care team? What do you recommend to others who might be struggling to communicate with their doctors? Share your thoughts in a comment below or in your Activities feed.

Kevin Benny has more than a decade of professional experience spanning education and market research. Learn more about him here.

A MyLungCancerTeam Member

Congratulations

November 4, 2022
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
Translation missing: lgc.site_noun_short News

Thank you for subscribing!

Become a member to get even more: